Last reviewed · How we verify
GSK 249553 vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
GSK 249553 vaccine (GSK 249553 vaccine) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GSK 249553 vaccine TARGET | GSK 249553 vaccine | GlaxoSmithKline | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GSK 249553 vaccine CI watch — RSS
- GSK 249553 vaccine CI watch — Atom
- GSK 249553 vaccine CI watch — JSON
- GSK 249553 vaccine alone — RSS
Cite this brief
Drug Landscape (2026). GSK 249553 vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/gsk-249553-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab